Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAA/TT Vaccine and Poly-ICLC for Pediatric Low-Grade Glioma
NCT02358187Phase 2Recruiting
- Start
- Jan 2015
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
A Phase 2 trial of GAA/TT peptide vaccine in low-grade glioma (LGG). Started Jan 2015; status: recruiting.
02
Drugs
GAA/TT peptide vaccine
03
Conditions
low-grade glioma (LGG)
Beyond the preview
Go deeper on NCT02358187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02358187.